Prognostic value of Mandard score and nodal status for recurrence patterns and survival after multimodal treatment of oesophageal adenocarcinoma.
Sofie P G HenckensDajia LiuSuzanne S GisbertzMarianne C KalffMaarten C J AndereggDavid CrullFreek DaamsAnnette D van DalsenJan Willem T DekkerMarc J van DetPeter van DuijvendijkWietse J EshuisRichard P R GroenendijkJan Willem HavemanRichard van HillegersbergMisha D P LuyerPim B OlthofJean-Pierre E N PierieVictor D PlatCamiel RosmanJelle P RuurdaJohanna W van SandickMeindert N SosefDaan M VoetenGuy H E J VijgenMaarten F BijlsmaSybren L MeijerMaarten C C M HulshofCesar OyarceSjoerd M LagardeHanneke W M van LaarhovenMark Ivo van Berge Henegouwennull nullPublished in: The British journal of surgery (2024)
Improved tumour response to neoadjuvant therapy was associated with lower recurrence rates and higher overall survival rates. Among patients with recurrent disease, TRG1 was associated with a higher incidence of brain recurrence than TRG>1. Residual nodal disease influenced prognosis more negatively than residual disease at the primary tumour site.